JP4606878B2 - 房水を外科的にバイパスするための装置 - Google Patents
房水を外科的にバイパスするための装置 Download PDFInfo
- Publication number
- JP4606878B2 JP4606878B2 JP2004538229A JP2004538229A JP4606878B2 JP 4606878 B2 JP4606878 B2 JP 4606878B2 JP 2004538229 A JP2004538229 A JP 2004538229A JP 2004538229 A JP2004538229 A JP 2004538229A JP 4606878 B2 JP4606878 B2 JP 4606878B2
- Authority
- JP
- Japan
- Prior art keywords
- tissue
- aqueous humor
- vein
- distal end
- stent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 210000001742 aqueous humor Anatomy 0.000 title claims description 46
- 210000003462 vein Anatomy 0.000 claims description 57
- 210000001519 tissue Anatomy 0.000 claims description 48
- 239000000463 material Substances 0.000 claims description 28
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 7
- 229920002674 hyaluronan Polymers 0.000 claims description 7
- 229960003160 hyaluronic acid Drugs 0.000 claims description 7
- 230000003287 optical effect Effects 0.000 claims description 7
- 238000002059 diagnostic imaging Methods 0.000 claims description 6
- 238000012423 maintenance Methods 0.000 claims description 5
- 239000003146 anticoagulant agent Substances 0.000 claims description 4
- 229960004676 antithrombotic agent Drugs 0.000 claims description 4
- 238000002604 ultrasonography Methods 0.000 claims description 4
- 239000000824 cytostatic agent Substances 0.000 claims description 3
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 3
- 238000012876 topography Methods 0.000 claims description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 2
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims description 2
- 229930012538 Paclitaxel Natural products 0.000 claims description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 claims description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 claims description 2
- 229960002897 heparin Drugs 0.000 claims description 2
- 229920000669 heparin Polymers 0.000 claims description 2
- 229960000485 methotrexate Drugs 0.000 claims description 2
- 229960001592 paclitaxel Drugs 0.000 claims description 2
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 claims description 2
- 229960002930 sirolimus Drugs 0.000 claims description 2
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 claims description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 claims description 2
- 230000010261 cell growth Effects 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 210000002159 anterior chamber Anatomy 0.000 description 30
- 238000000034 method Methods 0.000 description 22
- 238000001356 surgical procedure Methods 0.000 description 15
- 239000013307 optical fiber Substances 0.000 description 10
- -1 polyethylene Polymers 0.000 description 10
- 238000003384 imaging method Methods 0.000 description 8
- 208000002352 blister Diseases 0.000 description 7
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 239000007943 implant Substances 0.000 description 6
- 238000013459 approach Methods 0.000 description 5
- 230000004410 intraocular pressure Effects 0.000 description 5
- 208000010412 Glaucoma Diseases 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004087 cornea Anatomy 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004642 Polyimide Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001721 polyimide Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 210000003786 sclera Anatomy 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 210000001585 trabecular meshwork Anatomy 0.000 description 3
- 238000012800 visualization Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 229910001069 Ti alloy Inorganic materials 0.000 description 2
- HZEWFHLRYVTOIW-UHFFFAOYSA-N [Ti].[Ni] Chemical compound [Ti].[Ni] HZEWFHLRYVTOIW-UHFFFAOYSA-N 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 210000000795 conjunctiva Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000002657 fibrous material Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 230000000750 progressive effect Effects 0.000 description 2
- 239000012781 shape memory material Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000035965 Postoperative Complications Diseases 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000004240 ciliary body Anatomy 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000006837 decompression Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000005350 fused silica glass Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007257 malfunction Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 238000012634 optical imaging Methods 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/007—Methods or devices for eye surgery
- A61F9/00781—Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment
Description
a)眼の前部にある眼静脈に組織開口を形成するために装置を挿入する工程と、
b)静脈から房水源に至る管路を形成するために装置の向きを調整する工程と、
c)装置を取り除く工程と、
d)静脈と房水源との間の管路を通る流れを維持しつつ組織開口を閉じる工程と
を備える方法を開示する。
a)眼の中の組織開口から房水源に装置を挿入する工程と、
b)房水源から眼静脈に至る管路を形成するために装置の向きを調整する工程と、
c)静脈と房水源との間の管路を通る流れを維持しつつ装置を取り除く工程と、
d)組織開口を随意に閉じる工程と
によって形成される。
2…シュレム管
3…強膜
4…候補の脈
5…集水路
6…房水静脈
7…管路
8…顕微手術器具
9…繋ぎ目、進入ポイント
10…トロカール
11…外部被覆
12…ルアー継ぎ手
13…光ファイバの先端
14…光ファイバライン
15…エネルギ源
16…単純なチューブ
17…有窓のチューブ
18…ひと続きのフィラメントループ
19…小径セグメント
20…レーザ
21…形状記憶のインプラント
22…取り外し可能なチューブステント
23…駆動用のカニューレ
24…持ち手
Claims (20)
- 眼の強膜組織の内部に管路を形成するとともに、前記管路内に空間維持材料を配置するための装置であって、
房水が眼静脈に流れるための通路を構成する前記管路を形成するように成形された細長い本体部分を備え、
前記本体部分は、近位端および遠位端を有し、
前記遠位端は、強膜組織を通して見ることができる光ビーコンを有する、装置。 - 請求項1に記載の装置であって、
前記本体部分は、50〜500ミクロンの範囲の外径を有する、装置。 - 請求項1に記載の装置であって、
前記本体部分は、可撓性のマイクロカニューレを有する、装置。 - 請求項1に記載の装置であって、
前記遠位端は、機械的切断用先端部を有する、装置。 - 請求項1に記載の装置であって、
前記遠位端は、組織を焼灼するためのエネルギ源を有する、装置。 - 請求項5に記載の装置であって、
前記エネルギは、レーザ光、高周波エネルギ、または熱エネルギを含む、装置。 - 請求項1に記載の装置であって、
前記遠位端は、メディカルイメージングによって見ることができるものである、装置。 - 請求項7に記載の装置であって、
前記メディカルイメージングは、超音波または光干渉トポグラフィを含む、装置。 - 請求項1に記載の装置であって、
前記本体部分は、外部被覆および内部部材を有する、装置。 - 請求項9に記載の装置であって、
前記内部部材は、使用の最中に前記外部被覆から取り出すことができるものである、装置。 - 請求項1に記載の装置であって、更に、
前記管路の内部に配することができる空間維持材料を備える装置。 - 請求項11に記載の装置であって、
前記空間維持材料は、ヒアルロン酸を含む、装置。 - 請求項11に記載の装置であって、
前記空間維持材料は、細胞増殖抑制剤を含む、装置。 - 請求項11に記載の装置であって、
前記細胞増殖抑制剤は、メトトレキサート、パクリタキセル、またはシロリマスを含む、装置。 - 請求項11に記載の装置であって、
前記空間維持材料は、抗血栓剤を含む、装置。 - 請求項15に記載の装置であって
前記抗血栓剤は、ヘパリンまたは組織プラスミノゲン活性化因子を含む、装置。 - 請求項11に記載の装置であって、
前記空間維持材料は、ステント用具を含む、装置。 - 請求項17に記載の装置であって、
前記ステント用具は、ヒアルロン酸を含む、装置。 - 請求項17に記載の装置であって、
前記ステント用具は、ニッケル・チタン合金を含む、装置。 - 請求項17に記載の装置であって、
前記ステント用具は、その位置で第1の構成から第2の構成へと変化することができるものである、装置。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41166802P | 2002-09-17 | 2002-09-17 | |
US60/411,668 | 2002-09-17 | ||
PCT/US2003/029488 WO2004026347A2 (en) | 2002-09-17 | 2003-09-17 | Apparatus and method for surgical bypass of aqueous humor |
Publications (4)
Publication Number | Publication Date |
---|---|
JP2005538804A JP2005538804A (ja) | 2005-12-22 |
JP2005538804A5 JP2005538804A5 (ja) | 2006-11-09 |
JP4606878B2 true JP4606878B2 (ja) | 2011-01-05 |
JP4606878B6 JP4606878B6 (ja) | 2015-05-13 |
Family
ID=
Also Published As
Publication number | Publication date |
---|---|
CA2499094C (en) | 2011-07-19 |
US20100191103A1 (en) | 2010-07-29 |
US20060155300A1 (en) | 2006-07-13 |
WO2004026347A2 (en) | 2004-04-01 |
AU2003273339B2 (en) | 2008-08-14 |
EP1539066A4 (en) | 2008-05-21 |
JP2005538804A (ja) | 2005-12-22 |
WO2004026347A9 (en) | 2004-07-22 |
WO2004026347A3 (en) | 2004-06-03 |
EP1539066B1 (en) | 2012-11-07 |
CA2499094A1 (en) | 2004-04-01 |
EP1539066A2 (en) | 2005-06-15 |
AU2003273339A1 (en) | 2004-04-08 |
US7699882B2 (en) | 2010-04-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2499094C (en) | Apparatus and method for surgical bypass of aqueous humor | |
US10905590B2 (en) | Glaucoma treatment device | |
AU2005240123B2 (en) | Apparatus and method for surgical enhancement of aqueous humor drainage | |
EP2548538B1 (en) | Implantation systems for ocular implants with stiffness qualities | |
US20130253405A1 (en) | Ocular implant systems | |
AU2018200325B2 (en) | Glaucoma treatment device | |
JP4606878B6 (ja) | 房水を外科的にバイパスするための装置 | |
AU2014200171B2 (en) | Glaucoma treatment device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060919 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060919 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090602 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20090901 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090908 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20090908 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091119 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100223 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100928 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20101006 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20131015 Year of fee payment: 3 |
|
LAPS | Cancellation because of no payment of annual fees |